Avadel Pharmaceuticals Plc

Ownership Transactions Reported by 11 Insiders

Symbol
AVDL on Nasdaq
Industry
Pharmaceutical Preparations
Location
Block 10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland

Insiders trading volume in the past year

Avadel Pharmaceuticals Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mark Anthony McCamish Director $1.79M Jul 30, 2024
Gregory J. Divis Chief Executive Officer, Director $1.75M +$99.7K +6.03% Mar 5, 2025
Eric J. Ende Director $1.64M +$235K +16.8% Jan 13, 2025
Geoffrey Michael Glass Director $852K +$200K +30.6% Dec 10, 2024
Peter J. Thornton Director $837K +$80.5K +10.6% Jan 13, 2025
Thomas S. Mchugh Chief Financial Officer $796K +$76.5K +10.6% Mar 5, 2025
Linda Palczuk Director $538K +$70.2K +15% Jan 24, 2025
Jerad G. Seurer Gen. Counsel & Corp. Secretary $186K Mar 5, 2025
Naseem Amin Director $115K Jul 30, 2024
Richard J. Kim Chief Commercial Officer Feb 20, 2024
Douglas J. Williamson Chief Medical Officer Feb 14, 2022

Recent Insider Transactions by Companies or Individuals for Avadel Pharmaceuticals Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.